Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7801–7850 of 75496
On March 14, 2025, Primoris Services Corporation (“Primoris” or the “Company”) announced that David King, the Company’s Chairman and prior Chief Executive Officer (“CEO”), has been named Interim President and CEO.
On March 16, 2025, Morris A. Davis notified AGNC Investment Corp. (the "Company") of his immediate resignation and his decision not to stand for re-election to the Company's Board of Directors at the annual meeting of stockholders to be held on April 17, 2025 (the "Annual Meeting").
On March 14, 2025, we appointed Anthony Chapman to our Board of Directors for a three (3) year term.
Mr. Gan Kim Hai was appointed by the board of directors of the Company as chief executive officer and a director of the Company.
Pursuant to the Resignation Letter, Mr. Guo resigned as chief executive officer and director of the Company, effective March 17, 2025.
On March 19, 2025, in connection with the resignation of Bob R. Simpson, the Board appointed Brent W. Clum and Gary D. Simpson to serve as Co-Chief Executive Officers, effective April 1, 2025.
On March 19, 2025, in connection with the resignation of Bob R. Simpson, the Board appointed Brent W. Clum and Gary D. Simpson to serve as Co-Chief Executive Officers, effective April 1, 2025.
On March 19, 2025, the Board appointed Gary D. Simpson to serve as a member of the Board of the General Partner, effective April 1, 2025.
On March 19, 2025, Bob R. Simpson resigned from his position as Chief Executive Officer of TXO Partners GP, LLC (the “General Partner”), the general partner of TXO Partners, L.P. (the “Partnership”), effective April 1, 2025.
On March 18, 2024, each of Thomas W. Pettyjohn, Jr. and James F. Daly announced his intention not to seek re-election to the Board of Directors of the Bank of the James Financial Group, Inc. and its subsidiary Bank of the James.
On March 18, 2024, each of Thomas W. Pettyjohn, Jr. and James F. Daly announced his intention not to seek re-election to the Board of Directors of the Bank of the James Financial Group, Inc. and its subsidiary Bank of the James.
the Board appointed each of Akshay Naheta and Andrew Main, the current President and Chief Executive Officer of the Company, to serve as the Company’s Co-Chief Executive Officers (each a “Co-CEO” and together, the “Co-CEOs”), effective March 21, 2025.
Mr. Naheta also was appointed as a Class I Director of the Board, to serve until the 2025 annual meeting of stockholders.
the Board appointed each of Akshay Naheta and Andrew Main, the current President and Chief Executive Officer of the Company, to serve as the Company’s Co-Chief Executive Officers (each a “Co-CEO” and together, the “Co-CEOs”), effective March 21, 2025.
On March 18, 2025, Erick Lucera, Executive Vice President, Chief Financial Officer of Editas Medicine, Inc. (the “Company”) informed the Company that he will be resigning from his position effective March 28, 2025.
In connection with Mr. Lucera’s resignation, on March 19, 2025 the Company appointed Amy Parison, Senior Vice President, Finance as Senior Vice President, Chief Financial Officer and Treasurer of the Company, to be effective as of the close of business on March 28, 2025.
On March 19, 2025, the Board appointed Joseph P. Pellegrino, Jr., 60 years old, to fill the vacancy on the Board created with Peter Anania’s retirement.
On March 15, 2025, Peter Anania tendered his resignation from the Board of Directors (the “ Board ”) of Precision Optics Corporation, Inc. (the “ Company ”) retiring from the Board effective as of March 15, 2025.
On March 14, 2025, in connection with the IPO, Wei (Victor) Zhang, Daniel M. McCabe and Ping Zhang (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On March 14, 2025, in connection with the IPO, Wei (Victor) Zhang, Daniel M. McCabe and Ping Zhang (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
On March 14, 2025, in connection with the IPO, Wei (Victor) Zhang, Daniel M. McCabe and Ping Zhang (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
elected Ronald C. Keating as a director to fill the vacancy created by the expansion in the size of the Board.
the Board appointed Stephen J. Bacica as Chief Accounting Officer of the Company, effective as of March 19, 2025.
Mr. Bacica succeeds Kenneth F. Egan, who served as Interim Chief Accounting Officer of the Company from November 5, 2024 until March 19, 2025.
the Board of Directors (the “Board”) of Olaplex Holdings, Inc. (the “Company”) elected Pamela Edwards to serve as a Class II director of the Board, with a term expiring at the Company’s 2026 Annual Meeting of Stockholders, and appointed Ms. Edwards as a member of the Audit Committee of the Board (the “Audit Committee”), each effective as of March 19, 2025.
Also on March 17, 2025, Maha Radhakrishnan, M.D. informed the Company's board of directors (the "Board") that she will not stand for re-election as a Class I director at the Company's 2025 Annual Meeting of Stockholders.
On March 17, 2025, Jeff (Po Yu) Chen, Ph.D. informed the Company's board of directors (the "Board") that he will not stand for re-election as a Class I director at the Company's 2025 Annual Meeting of Stockholders.
On March 18, 2025, Christopher Stanley notified us of his resignation from Fannie’s Mae Board of Directors, effective as of that date.
On March 17, 2025, Edward P. Loomis, Jr., member of the Board of Directors of Colony Bankcorp, Inc. (the “Company”) and Colony Bank (the “Bank”), provided notice of his decision not to stand for reelection at the Company’s 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”).
Ms. Frances P. Grieb, an incumbent Class I director, informed the Board of her decision to retire from the Board effective at the 2025 annual meeting of stockholders and as a result to not seek to stand for re-election at the 2025 meeting.
Mr. Thomas E. Henning, having reached the retirement age of 72 on March 14, 2025, resigned from the registrant’s Board of Directors (the “Board”), with such resignation to become effective as of the registrant’s 2025 annual meeting of stockholders as provided in the guidelines.
At such time, Mr. Novak will vacate his current position on Comcast’s Board of Directors.
On March 13, 2025, it was determined that Masiar Tayebi, Executive Vice President, Chief Strategy and Information Officer of SpartanNash Company (the "Company"), will be leaving the Company, effective April 11, 2025.
On March 18, 2025, NeoGenomics, Inc. (the "Company") announced the promotion of Warren Stone, the Company's current Chief Commercial Officer, to the position of President & Chief Operating Officer, effective April 1, 2025.
Additionally, on March 18, 2025, the Company announced that the Chief Operations Officer and President, Oncology Data Solutions position is being eliminated and as a result, Melody Harris, the current Chief Operations Officer and President, Oncology Data Solutions will no longer hold such role effective April 1, 2025.
On March 17, 2025, the Board of Directors, through a vote of its Chairman and Directors appointed Mr. Andrew Acquarulo, Jr., 62, to serve a member of its Board of Directors.
Effective March 14, 2025 the board of directors of the Company appointed Joyce Martineau to replace Ms. Stone as the Company’s Chief Compliance Officer.
Effective March 14, 2025, Ileana Stone will no longer serve as Chief Compliance Officer of Lafayette Square USA, Inc. (the “Company”).
William Restrepo, the Company’s Chief Financial Officer, will transition from his role and retire as Chief Financial Officer on September 30, 2025.
it is expected that Miguel Rodriguez, Nabors' Senior Vice President of Finance Operations, will transition into the role of the Company’s Chief Financial Officer, upon Mr. Restrepo’s retirement on September 30, 2025.
On March 18, 2025, the Board of Directors (the “Board”) of AAR CORP. (the “Company”) increased the size of the Board to 12 members and elected Hema Widhani, 47, as a Class I independent director to fill the vacancy created by the increase, effective immediately.
On March 13, 2025, the Board of Directors of Alarm.com Holdings, Inc. (the “Company”) appointed Kevin Bradley as the Company’s Chief Financial Officer, effective as of March 14, 2025.
On March 19, 2025, our Board of Directors appointed Ms. Peggy Lamb as a member of our Board of Directors and as a member of our Compensation Committee effective March 19, 2025.
On March 18, 2025, the Board appointed Greg D. Calvert, age 59, as President of the Company, effective as of May 1, 2025.
On March 18, 2025, Mr. James J. Henson notified the Board of Directors (the “Board”) of the Company of his intention to resign as President of the Company, effective as of May 1, 2025.
On March 18, 2025, the Board of Directors of Vestis Corporation (the “Company” or “Vestis”) determined that Kim Scott, President and Chief Executive Officer, will leave her positions with the Company, effective March 18, 2025.
On March 18, 2025, the Company appointed Phillip Holloman, Chairman of the Board of Directors of the Company since September 2023, as interim Executive Chairman, President and Chief Executive Officer, effective March 18, 2025.
On March 18, 2025, Dr. Ruey-Bin Kao informed the Board of Directors (the “Board”) of iRobot Corporation (the “Company”) that he will not stand for re-election to the Board when his term expires at the Company’s upcoming 2025 annual meeting of stockholders.
On March 18, 2025, Bala S. Manian informed Vaccinex, Inc. (the “Company”) of his resignation as a director of the Company effective immediately.
appointed Tracey T. Travis to the Board effective March 18, 2025
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.